• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Santen Pharmaceutical Co Ltd

+ Add to Watchlist

SNPHY:US

22.8900 USD 0.1300 0.57%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Santen Pharmaceutical Co Ltd (SNPHY)

Open: 22.7900 Day's Range: 22.7900 - 22.8900 Volume: 403
Previous Close: 22.7600 52wk Range: 20.2900 - 25.8500 1-Yr Rtn: -4.55%

Stock Chart for SNPHY

No chart data available.
  • SNPHY:US 22.8900
  • 1D
  • 1M
  • 1Y
22.7600
Interactive SNPHY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNPHY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 3,780.04
Shares Outstanding (M) 165.14
30 Day Average Volume 588
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.13%
Cash Dividend (USD) -
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNPHY

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for SNPHY

SANTEN PHARMACEUTICAL CO., LTD. produces and sells ophthalmic medicine. The Company manufactures a variety of products including eye drops and ointments. Santen Pharmaceutical also imports lenses and tools and equipment used by optometrists and produces anti-rheumatic drugs.

Akira KurokawaPresident/CEOSadatoshi FurukadoSenior Managing Exec Officer
Masamichi SatoManaging Executive OfficerJyrki LiljeroosExecutive Officer
More Company Profile & Key Executives for SNPHY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil